Related Experiment Videos
Hereditary angio-oedema and C3 nephritic factor--HL-A study
Clinical Allergy
|September 1, 1979
Summary
Hereditary angio-oedema (HAE) in a six-generation family was linked to non-active C1 esterase inactivator (C1 INA) protein. Complement system anomalies, including C3 nephritic factor, were observed without clinical symptoms, and no linkage to HL-A loci was found.
Area of Science:
- Immunology
- Genetics
Background:
- Hereditary angio-oedema (HAE) is a rare genetic disorder.
- It arises from a defect in the C1 esterase inactivator (C1 INA) protein, a key regulator of the complement system.
- The complement system plays a crucial role in inflammation and immune responses.
Purpose of the Study:
- To investigate the genetic and molecular basis of HAE in a multi-generational family.
- To explore potential associations between HAE, complement system anomalies, and Human Leukocyte Antigen (HL-A) haplotypes.
Main Methods:
- Functional testing of C1 esterase inactivator (C1 INA) protein in affected family members.
- Analysis of the complement system for anomalies, specifically C3 nephritic factor.
- Study of Human Leukocyte Antigen (HL-A) haplotypes to assess linkage.
Main Results:
- Nine out of twenty-four family members exhibited non-active C1 esterase inactivator (C1 INA) protein.
- C3 nephritic factor was identified in the complement system of affected individuals, without associated renal or clinical symptoms.
- No linkage was found between HAE and HL-A loci A, B, and C.
Conclusions:
- The study confirms a defect in C1 esterase inactivator (C1 INA) as the cause of HAE in this family.
- The presence of C3 nephritic factor suggests broader complement system dysregulation in HAE patients.
- No genetic linkage between HAE and the studied HL-A loci was observed in this family.